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Fig. 1. Blood glucose concentrations of 120 minutes of steady state exercise 
at 50% of VO2 peak. 
No differences were found between placebo and histamine receptor 
blockade groups (p = 0.801), and no Group X Time Interaction was 
determined (p = 0.881). Blood glucose levels at 15, 60, and 105 minutes are 
lower than the pre-exercise levels (p<0.001). 
This was a double-blind placebo-controlled study. 6 men and 3 women completed two 
familiarization 10K time trials prior to the study visits. Study visits were performed in a 
semi-random order and all time trials were performed at the same time of day in a 18°C, 
45% RH controlled environment. 1 hour before performing 120 minutes of cycling 
exercise at 50% VO2 peak, subjects received either placebo or an oral H1/H2 histamine 
receptor blockade (540 mg Fexofenadine, and 300 mg Ranitidine). Blood samples were 
acquired from an ear lobe puncture and measured using a handheld Precision Xtra
Blood Glucose Monitoring System (Abbot Diabetes Care INC, Alameda CA) pre-exercise 
and 3 times during exercise at 15, 60, and 105 minutes). 
Statistics. The results were analyzed with a repeated-measures two-way ANOVA (RM 
ANOVA, Group X Time) to estimate differences between groups (Placebo vs. Antagonist) 
over time (Pre-Exercise, 15, 60, 105 minutes). 
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ABSTRACT
INTRODUCTION
METHODS
CONCLUSIONS
Ø Blood glucose concentration decreased with cycling exercise at 
50% VO2 peak (Zinker 1990).
Ø Histamine receptor blockade (H1/H2) reduced interstitial glucose 
concentrations within skeletal muscle during recovery from 
exercise (Pellinger 2010).
Ø Histamine receptor blockade (H1/H2) reduced blood flow and 
therefore glucose delivery to skeletal muscle following exercise, 
and the effect may be more relevant in highly fit individuals 
(Emhoff 2011). 
Ø Additionally histamine receptor blockade (H1/H2) reduced whole-
body insulin sensitivity by 25% following exercise (Pellinger
2013). 
Ø The effect of histamine receptor blockades (H1/H2)  on blood 
glucose during exercise is unknown.
Ø The purpose of this experiment was to determine if H1/H2
histamine receptor blockades would decrease blood glucose 
concentrations during exercise. It was hypothesized that blood 
glucose concentration would decrease during exercise with the 
histamine receptor blockade (H1/H2 ).
The primary findings from this study are:
1. Both placebo and histamine receptor blockade groups rose in blood 
glucose levels between 20-60 minutes, then stayed consistent between 
60-105 minutes. No significant differences were found between the 
groups.
2. A significant difference in blood glucose concentrations over time was 
found. Pre-exercise blood glucose levels are higher than at minutes 15, 
60, and 105 of exercise. 
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The future study goals are:
Ø To learn the effects of histamine receptor blockade during exercise on 
skeletal muscle glucose concentration in a very fit population. 
FUTURE STUDIES
Histamine has been found to be an important component during the 
exercise recovery period, particularly in mediating vasodilation, 
hyperemia, and hypotension. Blocking H1/H2 histamine receptors 
produced altered outcomes during recovery, including a decrease in 
interstitial glucose concentrations and reductions in blood flow and 
whole-body insulin sensitivity. It is unknown if blood glucose 
concentrations change with histamine receptor blockades, specifically 
during the exercise period. PURPOSE: To determine if H1/H2
histamine receptor blockades decrease blood glucose concentrations 
during exercise. HYPOTHESIS: It was hypothesized that histamine 
receptor blockade would decrease blood glucose concentrations 
during exercise. METHODS: Nine competitive cyclists performed 120 
minutes of cycling exercise at 50% VO2 peak. 60 minutes prior to 
exercise, subjects were given either a placebo or histamine receptor 
blockades (540 mg Fexofenadine and 300 mg Ranitidine). Blood 
glucose concentrations were measured using a handheld Precision 
Xtra Blood Glucose Monitoring System (Abbot Diabetes Care INC, 
Alameda CA). Measurements were taken from the earlobe pre-
exercise and three times during exercise at 15, 60, and 120 minutes. 
A repeated-measures two-way ANOVA (RM ANOVA, Group X Time) 
was used for statistical analysis. RESULTS: No differences were 
found between placebo and histamine receptor blockades groups (p = 
0.801), and no Group X Time Interaction was determined (p = 0.881). 
Blood glucose levels at 15, 60, and 105 minutes were lower than the 
pre-exercise levels (p<0.001). CONCLUSION: No significant 
differences in blood glucose concentrations were found between 
placebo and histamine receptor blockade groups.
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Table 1. Subject Characteristics 
n 
Age (yrs) 
Heigl1t ( c111) 
W eigl1t (kg) 
Body Fat(%) 
Peak Power (Watts) 
V02 peak (1111 ·kg-l ·111ir1-1) 
KI1ee-extensio11 iso111etric force (N) 
50% V02 peak Workload (Watts) 
Valt1es are 111eans ± SD. 
I 
l l l l 
I 
• 
9 (3F, 9M) 
27 ± 6 
175 .7 ± 9.8 
70.52 ± 13.75 
16.7 ± 10.7 
897 ± 262 
58.1 ± 6.8 
58 1.7±235. 1 
155 ± 35 
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